Starlink Medicines in Jurassic Healthcare Systems-Are We Ready?

IF 3.7 4区生物学 Q2 GENETICS & HEREDITY

CRISPR Journal Pub Date : 2025-05-21 DOI:10.1089/crispr.2025.0042

Tay Salimullah

引用次数: 0

Abstract

Genomic medicines are transforming the landscape of human health-but their promise risks being confined to the few. While science has entered the 21^st century, most health systems remain unequipped to deliver one-time curative therapies. This essay calls for a global reckoning: what do we truly value in innovation, and how can we align systems, incentives, and ethics to democratize access? Drawing on real-world experience across four continents, it argues for a new social compact-embedding equity, rethinking value, and modernizing delivery-to ensure that the miracles of modern medicine become global, sustainable, and just.

查看原文本刊更多论文

侏罗纪医疗系统中的星链药物——我们准备好了吗？

基因组药物正在改变人类健康的面貌，但它们的前景可能仅限于少数人。虽然科学已进入21世纪，但大多数卫生系统仍然没有提供一次性治疗的能力。本文呼吁全球反思：我们在创新中真正看重的是什么？我们如何协调制度、激励机制和道德规范，使获取民主化？报告借鉴了四大洲的实际经验，提出了一种新的社会契约——嵌入公平、重新思考价值和实现交付现代化——以确保现代医学的奇迹成为全球性、可持续性和公正的。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

CRISPR Journal Biochemistry, Genetics and Molecular Biology-Biotechnology

CiteScore

6.30

自引率

2.70%

发文量

期刊介绍： In recognition of this extraordinary scientific and technological era, Mary Ann Liebert, Inc., publishers recently announced the creation of The CRISPR Journal -- an international, multidisciplinary peer-reviewed journal publishing outstanding research on the myriad applications and underlying technology of CRISPR. Debuting in 2018, The CRISPR Journal will be published online and in print with flexible open access options, providing a high-profile venue for groundbreaking research, as well as lively and provocative commentary, analysis, and debate. The CRISPR Journal adds an exciting and dynamic component to the Mary Ann Liebert, Inc. portfolio, which includes GEN (Genetic Engineering & Biotechnology News) and more than 80 leading peer-reviewed journals.